These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7854544)

  • 1. Frequency of anti-nuclear antibodies in multiple sclerosis.
    Barned S; Goodman AD; Mattson DH
    Neurology; 1995 Feb; 45(2):384-5. PubMed ID: 7854544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and significance of antinuclear antibodies in multiple sclerosis.
    Collard RC; Koehler RP; Mattson DH
    Neurology; 1997 Sep; 49(3):857-61. PubMed ID: 9305354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis.
    Fujii T; Yamasaki R; Miyachi Y; Nagata S; Maimaitijiang G; Nakamura Y; Shinoda K; Matsushita T; Isobe N; Kira JI
    J Neurol Sci; 2020 Feb; 409():116619. PubMed ID: 31835211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antinuclear antibodies in multiple sclerosis].
    Antigüedad A; Ruiz J; Mendibe MM; Zarranz JJ
    Neurologia; 1997; 12(6):245-8. PubMed ID: 9303591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies to native and denatured DNA in multiple sclerosis].
    Alifirova VM; Krotenko NV; Krotenko NM; Ivanova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):16-20. PubMed ID: 21916154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis.
    Szmyrka-Kaczmarek M; Pokryszko-Dragan A; Pawlik B; Gruszka E; Korman L; Podemski R; Wiland P; Szechinski J
    Lupus; 2012 Apr; 21(4):412-20. PubMed ID: 22074845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-nuclear antibodies and the optic-spinal form of multiple sclerosis.
    Fukazawa T; Kikuchi S; Sasaki H; Hamada K; Hamada T; Miyasaka K; Tashiro K
    J Neurol; 1997 Aug; 244(8):483-8. PubMed ID: 9309553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies.
    Spadaro M; Amendolea MA; Mazzucconi MG; Fantozzi R; Di Lello R; Zangari P; Masala G
    Mult Scler; 1999 Apr; 5(2):121-5. PubMed ID: 10335521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients.
    Roussel V; Yi F; Jauberteau MO; Couderq C; Lacombe C; Michelet V; Gil R; Couratier P; Vallat JM; Preud'homme JL
    J Autoimmun; 2000 May; 14(3):259-65. PubMed ID: 10756088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupoid sclerosis: what is the role of antiphospholipid antibodies?
    Lima I; Melo A; Brandi IV; Costa O; Santiago M
    J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
    Stich O; Perera S; Berger B; Jarius S; Wildemann B; Baumgartner A; Rauer S
    J Neurol Sci; 2016 May; 364():29-32. PubMed ID: 27084211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica.
    Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S
    Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical utility of a positive antinuclear antibody test result.
    Abeles AM; Abeles M
    Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].
    Mierau R
    Z Rheumatol; 2016 May; 75(4):372-80. PubMed ID: 26820723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.
    Wu L; Huang D; Yang Y; Wu W
    Eur Neurol; 2014; 72(1-2):103-8. PubMed ID: 24993096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinuclear antibody assay: developing criteria for reflexive anti-dsDNA antibody testing in a laboratory setting.
    Craig WY; Ledue TB
    Clin Chem Lab Med; 2011 Jul; 49(7):1205-11. PubMed ID: 21612543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is high titre ANA specific for connective tissue disease?
    Vaile JH; Dyke L; Kherani R; Johnston C; Higgins T; Russell AS
    Clin Exp Rheumatol; 2000; 18(4):433-8. PubMed ID: 10949716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.